Form 4: Maravai LifeSciences Executive Peter Leddy Reports Acquisition of Class A Common Stock
SEC Form 4
Peter Michael Leddy, Chief Administrative Officer of Maravai LifeSciences Holdings, Inc., reports acquiring 394,478 shares of Class A Common Stock through restricted stock units.
Summary
- Peter Michael Leddy, Chief Administrative Officer of Maravai LifeSciences Holdings, Inc., filed a Form 4 on March 19, 2025.
- The report details a transaction on March 17, 2025, where Leddy acquired 394,478 shares of Class A Common Stock.
- These shares were acquired through restricted stock units (RSUs) awarded under the company's 2020 Omnibus Incentive Plan.
- Each RSU represents the right to receive one share of Class A Common Stock upon vesting.
- The RSUs vest in three equal installments on March 15, 2026, March 15, 2027, and March 15, 2028, contingent upon Leddy's continued employment.
- Following the reported transaction, Leddy beneficially owns 732,331 shares of Class A Common Stock directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by an executive, which can be seen as a positive sign of confidence, but it's not a major event.
Positives
- The acquisition of shares by a high-ranking executive could be interpreted as a positive sign of confidence in the company's future.
Future Outlook
The vesting schedule of the RSUs (March 15, 2026, March 15, 2027, and March 15, 2028) is contingent upon the Reporting Person's continued employment with the Issuer.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the ownership stakes of company executives.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key executive.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction: Acquisition of Class A Common Stock via RSUs. |
| 03/15/2026 | First vesting date for 1/3rd of the RSUs. |
| 03/15/2027 | Second vesting date for 1/3rd of the RSUs. |
| 03/15/2028 | Final vesting date for 1/3rd of the RSUs. |
| 03/19/2025 | Date of Form 4 filing. |
Keywords
Maravai LifeSciences, MRVI, Peter Leddy, Form 4, insider trading, restricted stock units, RSUs, Class A Common Stock, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.